Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure supports the development of novel agents with potential antidepressant or antipsychotic activity. The presence of trifluoromethyl and benzyl groups enhances metabolic stability and binding selectivity, making it valuable in optimizing drug candidates. Also explored in medicinal chemistry for structure-activity relationship (SAR) studies due to its stereochemical configuration and functional handle for further derivatization.